The risk of thrombosis after acute-COVID-19 infection

Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has been associated with coagulation dysfunction which predisposes patients to an increased risk of both venous and arterial thromboembolism, increasing the short-term morbidity and mortality. Current data evidenced that the rate...

Full description

Saved in:
Bibliographic Details
Published inQJM : An International Journal of Medicine Vol. 114; no. 9; pp. 619 - 620
Main Authors Zuin, M, Rigatelli, G, Zuliani, G, Roncon, L
Format Journal Article Web Resource
LanguageEnglish
Published England Oxford University Press 15.03.2021
Subjects
COVID-19
follow-up
thrombosis
Online AccessGet full text

Cover

More Information
Summary:Abstract Severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) has been associated with coagulation dysfunction which predisposes patients to an increased risk of both venous and arterial thromboembolism, increasing the short-term morbidity and mortality. Current data evidenced that the rate of post-discharge thrombotic events in COVID-19 patients is lower compared to that observed during hospitalization. Rather than ‘true thrombotic events’, these complications seem more probably ‘immunothrombosis’ consequent to the recent infection. Unfortunately, the absence of data from randomized controlled trials, large prospective cohorts and ambulatory COVID-19 patients, left unresolved the question regarding the need of post-discharge thromboprophylaxis due to the absence of strong‐level recommendations.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1460-2725
1460-2393
DOI:10.1093/qjmed/hcab054